Konrad Glund is a Co-Founder of Vivoryon Therapeutics NV, a clinical-stage biopharmaceutical company focused on small molecule-based medicines.
Konrad Glund is a Co-Founder of Vivoryon Therapeutics NV, a clinical-stage biopharmaceutical company focused on small molecule-based medicines for Alzheimer's disease. He previously served as CEO of Probiodrug, the company that evolved into Vivoryon Therapeutics. Glund is currently listed as an Advisor to Vivoryon Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide